arrow
L

Luc G. Berthiaume

University of Alberta
H指数:33
被引数:4,203

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A first-in-human phase I trial of daily oral zelenirstat, a N-myristoyltransferase inhibitor, in patients with advanced solid tumors and relapsed/refractory B-cell lymphomas

在患有晚期实体瘤和复发/难治性b细胞淋巴瘤的患者中,每日口服N-肉豆蔻酰转移酶抑制剂zelenirstat的首次人体I期试验

2024-06-052
OAAI
Targeting N-myristoylation for therapy of B-cell lymphomas
2020-10-2243
OAAI
Targeting N-myristoylation in B-cell lymphomas as a therapeutic strategy
2020-08-150
PRE
Targeting N-myristoylation in B cell lymphomas as a therapeutic strategy
2019-07-010
PRE